Mario Gabelli's ZBH Position Overview
Mario Gabelli (via Gamco Investors, Inc. Et Al) currently holds 231,974 shares of Zimmer Biomet Holdings, Inc. (ZBH) worth $20.86 M, representing 0.20% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 51 quarters.
Based on 13F filings since 2013, Mario Gabelli has maintained a long-term strategic position in ZBH, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2017, adding 178,269 shares. Largest reduction occurred in Q3 2018, reducing 54,724 shares.
Analysis based on 13F filings available since 2013 Q2
Mario Gabelli's Zimmer Biomet Holdings (ZBH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Zimmer Biomet Holdings (ZBH) Trades by Mario Gabelli
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -7,869 | Reduce 3.28% | 231,974 | $89.92 |
| Q3 2025 | -6,112 | Reduce 2.49% | 239,843 | $98.50 |
| Q2 2025 | +45,164 | Add 22.49% | 245,955 | $91.21 |
| Q1 2025 | -7,610 | Reduce 3.65% | 200,791 | $113.18 |
| Q4 2024 | -4,931 | Reduce 2.31% | 208,401 | $105.63 |
| Q3 2024 | -1,856 | Reduce 0.86% | 213,332 | $107.95 |
| Q2 2024 | -11,815 | Reduce 5.20% | 215,188 | $108.53 |
| Q1 2024 | -2,432 | Reduce 1.06% | 227,003 | $131.98 |
| Q4 2023 | -7,351 | Reduce 3.10% | 229,435 | $121.70 |
| Q3 2023 | -18,398 | Reduce 7.21% | 236,786 | $112.22 |
| Q2 2023 | -16,149 | Reduce 5.95% | 255,184 | $145.60 |
| Q1 2023 | -37,981 | Reduce 12.28% | 271,333 | $129.20 |
| Q4 2022 | -5,564 | Reduce 1.77% | 309,314 | $127.50 |
| Q3 2022 | -1,490 | Reduce 0.47% | 314,878 | $104.55 |
| Q2 2022 | +12,655 | Add 4.17% | 316,368 | $105.06 |
| Q1 2022 | +23,754 | Add 8.48% | 303,713 | $127.90 |
| Q4 2021 | -1,571 | Reduce 0.56% | 279,959 | $123.34 |
| Q3 2021 | +11,573 | Add 4.29% | 281,530 | $142.10 |
| Q2 2021 | +1,321 | Add 0.49% | 269,957 | $156.14 |
| Q1 2021 | -3,786 | Reduce 1.39% | 268,636 | $155.42 |
| Q4 2020 | -7,805 | Reduce 2.79% | 272,422 | $149.60 |
| Q3 2020 | -19,014 | Reduce 6.35% | 280,227 | $132.17 |
| Q2 2020 | -50,078 | Reduce 14.34% | 299,241 | $115.88 |
| Q1 2020 | -15,645 | Reduce 4.29% | 349,319 | $98.14 |
| Q4 2019 | -15,805 | Reduce 4.15% | 364,964 | $145.32 |
| Q3 2019 | -35,340 | Reduce 8.49% | 380,769 | $133.27 |
| Q2 2019 | -16,827 | Reduce 3.89% | 416,109 | $114.31 |
| Q1 2019 | -26,602 | Reduce 5.79% | 432,936 | $123.98 |
| Q4 2018 | -39,794 | Reduce 7.97% | 459,538 | $100.70 |
| Q3 2018 | -54,724 | Reduce 9.88% | 499,332 | $127.64 |
| Q2 2018 | -26,830 | Reduce 4.62% | 554,056 | $108.19 |
| Q1 2018 | +48,588 | Add 9.13% | 580,886 | $105.86 |
| Q4 2017 | +31,801 | Add 6.35% | 532,298 | $117.16 |
| Q3 2017 | +178,269 | Add 55.32% | 500,497 | $113.68 |
| Q2 2017 | +38,729 | Add 13.66% | 322,228 | $124.66 |
| Q1 2017 | +52,798 | Add 22.89% | 283,499 | $118.55 |
| Q4 2016 | -4,214 | Reduce 1.79% | 230,701 | $100.19 |
| Q3 2016 | -14,656 | Reduce 5.87% | 234,915 | $126.23 |
| Q2 2016 | -4,429 | Reduce 1.74% | 249,571 | $116.87 |
| Q1 2016 | -20,806 | Reduce 7.57% | 254,000 | $103.52 |
| Q4 2015 | -2,678 | Reduce 0.97% | 274,806 | $99.60 |
| Q3 2015 | -19,483 | Reduce 6.56% | 277,484 | $91.19 |
| Q2 2015 | -14,986 | Reduce 4.80% | 296,967 | $106.05 |
| Q1 2015 | -1,854 | Reduce 0.59% | 311,953 | $114.10 |
| Q4 2014 | -9,084 | Reduce 2.81% | 313,807 | $110.12 |
| Q3 2014 | +5,526 | Add 1.74% | 322,891 | $97.62 |
| Q2 2014 | -289 | Reduce 0.09% | 317,365 | $100.83 |
| Q1 2014 | -7,313 | Reduce 2.25% | 317,654 | $91.83 |
| Q4 2013 | -1,906 | Reduce 0.58% | 324,967 | $90.48 |
| Q3 2013 | -12,154 | Reduce 3.58% | 326,873 | $79.75 |
| Q2 2013 | +339,027 | Add 0.00% | 339,027 | $72.76 |
Mario Gabelli's Zimmer Biomet Holdings Investment FAQs
Mario Gabelli first purchased Zimmer Biomet Holdings, Inc. (ZBH) in Q2 2013, acquiring 339,027 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli has held Zimmer Biomet Holdings, Inc. (ZBH) for 51 quarters since Q2 2013.
Mario Gabelli's largest addition to Zimmer Biomet Holdings, Inc. (ZBH) was in Q2 2013, adding 339,027 shares worth $24.67 M.
According to the latest 13F filing for Q4 2025, Mario Gabelli's firm, Gamco Investors, Inc. Et Al, owns 231,974 shares of Zimmer Biomet Holdings, Inc. (ZBH), valued at approximately $20.86 M.
As of the Q4 2025 filing, Zimmer Biomet Holdings, Inc. (ZBH) represents approximately 0.20% of Mario Gabelli's publicly disclosed stock portfolio, making it one of their key holdings.
Mario Gabelli's peak holding in Zimmer Biomet Holdings, Inc. (ZBH) was 580,886 shares, as reported at the end of Q1 2018.